Molecular evidence supporting field effect in urothelial carcinogenesis

Timothy D. Jones, Mingsheng Wang, John Eble, Gregory T. MacLennan, Antonio Lopez-Beltran, Shaobo Zhang, Amy Cocco, Liang Cheng

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Purpose: Human urothelial carcinoma is thought to arise from a field change that affects the entire urothelium. Multifocality of urothelial carcinoma is a common finding at endoscopy and surgery. Whether these coexisting tumors arise independently or are derived from the same tumor clone is uncertain. Molecular analysis of microsatellite alterations and X-chromosome inactivation status in the cells from each coexisting tumor may further our understanding of urothelial carcinogenesis. Experimental Design: We examined 58 tumors from 21 patients who underwent surgical excision for urothelial carcinoma. All patients had multiple separate foci of urothelial carcinoma (two to four) within the urinary tract. Genomic DNA samples were prepared from formalin-fixed, paraffin-embedded tissue sections using laser-capture microdissection. Loss of heterozygosity (LOH) assays for three microsatellite polymorphic markers on chromosome 9p21 (IFNA and D9S171), regions of putative tumor suppressor gene p16, and on chromosome 17p13 (TP53), the p53 tumor suppressor gene locus, were done. X-chromosome inactivation analysis was done on the urothelial tumors from 11 female patients. Results: Seventeen of 21 (81%) cases showed allelic loss in one or more of the urothelial tumors in at least one of the three polymorphic markers analyzed. Concordant allelic loss patterns between each coexisting urothelial tumor were seen in only 3 of 21 (14%) cases. A concordant pattern of nonrandom X-chromosome inactivation in the multiple coexisting urothelial tumors was seen in only 3 of 11 female patients; of these 3 cases, only one displayed an identical allelic loss pattern in all of the tumors on LOH analysis. Conclusion: LOH and X-chromosome inactivation assays show that the coexisting tumors in many cases of multifocal urothelial carcinoma have a unique clonal origin and arise from independently transformed progenitor urothelial cells, supporting the "field effect" theory for urothelial carcinogenesis.

Original languageEnglish
Pages (from-to)6512-6519
Number of pages8
JournalClinical Cancer Research
Volume11
Issue number18
DOIs
StatePublished - Sep 15 2005

Fingerprint

Carcinogenesis
Loss of Heterozygosity
X Chromosome Inactivation
Neoplasms
Carcinoma
Tumor Suppressor Genes
Microsatellite Repeats
Chromosomes
Laser Capture Microdissection
Urothelium
Urinary Tract
Paraffin
Formaldehyde
Endoscopy
Research Design
Stem Cells
Clone Cells
DNA

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Molecular evidence supporting field effect in urothelial carcinogenesis. / Jones, Timothy D.; Wang, Mingsheng; Eble, John; MacLennan, Gregory T.; Lopez-Beltran, Antonio; Zhang, Shaobo; Cocco, Amy; Cheng, Liang.

In: Clinical Cancer Research, Vol. 11, No. 18, 15.09.2005, p. 6512-6519.

Research output: Contribution to journalArticle

Jones, Timothy D. ; Wang, Mingsheng ; Eble, John ; MacLennan, Gregory T. ; Lopez-Beltran, Antonio ; Zhang, Shaobo ; Cocco, Amy ; Cheng, Liang. / Molecular evidence supporting field effect in urothelial carcinogenesis. In: Clinical Cancer Research. 2005 ; Vol. 11, No. 18. pp. 6512-6519.
@article{dd3a4d2c972941f5ac0f0f01be9edcd6,
title = "Molecular evidence supporting field effect in urothelial carcinogenesis",
abstract = "Purpose: Human urothelial carcinoma is thought to arise from a field change that affects the entire urothelium. Multifocality of urothelial carcinoma is a common finding at endoscopy and surgery. Whether these coexisting tumors arise independently or are derived from the same tumor clone is uncertain. Molecular analysis of microsatellite alterations and X-chromosome inactivation status in the cells from each coexisting tumor may further our understanding of urothelial carcinogenesis. Experimental Design: We examined 58 tumors from 21 patients who underwent surgical excision for urothelial carcinoma. All patients had multiple separate foci of urothelial carcinoma (two to four) within the urinary tract. Genomic DNA samples were prepared from formalin-fixed, paraffin-embedded tissue sections using laser-capture microdissection. Loss of heterozygosity (LOH) assays for three microsatellite polymorphic markers on chromosome 9p21 (IFNA and D9S171), regions of putative tumor suppressor gene p16, and on chromosome 17p13 (TP53), the p53 tumor suppressor gene locus, were done. X-chromosome inactivation analysis was done on the urothelial tumors from 11 female patients. Results: Seventeen of 21 (81{\%}) cases showed allelic loss in one or more of the urothelial tumors in at least one of the three polymorphic markers analyzed. Concordant allelic loss patterns between each coexisting urothelial tumor were seen in only 3 of 21 (14{\%}) cases. A concordant pattern of nonrandom X-chromosome inactivation in the multiple coexisting urothelial tumors was seen in only 3 of 11 female patients; of these 3 cases, only one displayed an identical allelic loss pattern in all of the tumors on LOH analysis. Conclusion: LOH and X-chromosome inactivation assays show that the coexisting tumors in many cases of multifocal urothelial carcinoma have a unique clonal origin and arise from independently transformed progenitor urothelial cells, supporting the {"}field effect{"} theory for urothelial carcinogenesis.",
author = "Jones, {Timothy D.} and Mingsheng Wang and John Eble and MacLennan, {Gregory T.} and Antonio Lopez-Beltran and Shaobo Zhang and Amy Cocco and Liang Cheng",
year = "2005",
month = "9",
day = "15",
doi = "10.1158/1078-0432.CCR-05-0891",
language = "English",
volume = "11",
pages = "6512--6519",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "18",

}

TY - JOUR

T1 - Molecular evidence supporting field effect in urothelial carcinogenesis

AU - Jones, Timothy D.

AU - Wang, Mingsheng

AU - Eble, John

AU - MacLennan, Gregory T.

AU - Lopez-Beltran, Antonio

AU - Zhang, Shaobo

AU - Cocco, Amy

AU - Cheng, Liang

PY - 2005/9/15

Y1 - 2005/9/15

N2 - Purpose: Human urothelial carcinoma is thought to arise from a field change that affects the entire urothelium. Multifocality of urothelial carcinoma is a common finding at endoscopy and surgery. Whether these coexisting tumors arise independently or are derived from the same tumor clone is uncertain. Molecular analysis of microsatellite alterations and X-chromosome inactivation status in the cells from each coexisting tumor may further our understanding of urothelial carcinogenesis. Experimental Design: We examined 58 tumors from 21 patients who underwent surgical excision for urothelial carcinoma. All patients had multiple separate foci of urothelial carcinoma (two to four) within the urinary tract. Genomic DNA samples were prepared from formalin-fixed, paraffin-embedded tissue sections using laser-capture microdissection. Loss of heterozygosity (LOH) assays for three microsatellite polymorphic markers on chromosome 9p21 (IFNA and D9S171), regions of putative tumor suppressor gene p16, and on chromosome 17p13 (TP53), the p53 tumor suppressor gene locus, were done. X-chromosome inactivation analysis was done on the urothelial tumors from 11 female patients. Results: Seventeen of 21 (81%) cases showed allelic loss in one or more of the urothelial tumors in at least one of the three polymorphic markers analyzed. Concordant allelic loss patterns between each coexisting urothelial tumor were seen in only 3 of 21 (14%) cases. A concordant pattern of nonrandom X-chromosome inactivation in the multiple coexisting urothelial tumors was seen in only 3 of 11 female patients; of these 3 cases, only one displayed an identical allelic loss pattern in all of the tumors on LOH analysis. Conclusion: LOH and X-chromosome inactivation assays show that the coexisting tumors in many cases of multifocal urothelial carcinoma have a unique clonal origin and arise from independently transformed progenitor urothelial cells, supporting the "field effect" theory for urothelial carcinogenesis.

AB - Purpose: Human urothelial carcinoma is thought to arise from a field change that affects the entire urothelium. Multifocality of urothelial carcinoma is a common finding at endoscopy and surgery. Whether these coexisting tumors arise independently or are derived from the same tumor clone is uncertain. Molecular analysis of microsatellite alterations and X-chromosome inactivation status in the cells from each coexisting tumor may further our understanding of urothelial carcinogenesis. Experimental Design: We examined 58 tumors from 21 patients who underwent surgical excision for urothelial carcinoma. All patients had multiple separate foci of urothelial carcinoma (two to four) within the urinary tract. Genomic DNA samples were prepared from formalin-fixed, paraffin-embedded tissue sections using laser-capture microdissection. Loss of heterozygosity (LOH) assays for three microsatellite polymorphic markers on chromosome 9p21 (IFNA and D9S171), regions of putative tumor suppressor gene p16, and on chromosome 17p13 (TP53), the p53 tumor suppressor gene locus, were done. X-chromosome inactivation analysis was done on the urothelial tumors from 11 female patients. Results: Seventeen of 21 (81%) cases showed allelic loss in one or more of the urothelial tumors in at least one of the three polymorphic markers analyzed. Concordant allelic loss patterns between each coexisting urothelial tumor were seen in only 3 of 21 (14%) cases. A concordant pattern of nonrandom X-chromosome inactivation in the multiple coexisting urothelial tumors was seen in only 3 of 11 female patients; of these 3 cases, only one displayed an identical allelic loss pattern in all of the tumors on LOH analysis. Conclusion: LOH and X-chromosome inactivation assays show that the coexisting tumors in many cases of multifocal urothelial carcinoma have a unique clonal origin and arise from independently transformed progenitor urothelial cells, supporting the "field effect" theory for urothelial carcinogenesis.

UR - http://www.scopus.com/inward/record.url?scp=25144513898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25144513898&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-05-0891

DO - 10.1158/1078-0432.CCR-05-0891

M3 - Article

C2 - 16166427

AN - SCOPUS:25144513898

VL - 11

SP - 6512

EP - 6519

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 18

ER -